AR036591A1 - Uso de la hl en hiperestimulacion ovarica controlada - Google Patents
Uso de la hl en hiperestimulacion ovarica controladaInfo
- Publication number
- AR036591A1 AR036591A1 ARP020103455A ARP020103455A AR036591A1 AR 036591 A1 AR036591 A1 AR 036591A1 AR P020103455 A ARP020103455 A AR P020103455A AR P020103455 A ARP020103455 A AR P020103455A AR 036591 A1 AR036591 A1 AR 036591A1
- Authority
- AR
- Argentina
- Prior art keywords
- day
- hoc
- controlled
- hyperestimulation
- ovaric
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Uso de la HL, y análogos que poseen actividad de HL, para asistir en la foliculogénesis en la hiperestimulación ovárica controlada (HOC), en la que la HL o un análogo de la misma se administra durante un período de preparación que dura desde el primer día hasta aproximadamente el cuarto día de la fase estimulante de la HOC. Reivindicación 11: Una composición farmacéutica para aumentar la foliculogénesis, que comprende HL o un análogo de la misma, a una dosis diaria de 20-400 IU de la HL, para administrarse desde el primer día hasta aproximadamente el cuarto día de la fase estimulante de la HOC.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01307755 | 2001-09-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR036591A1 true AR036591A1 (es) | 2004-09-22 |
Family
ID=8182260
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020103455A AR036591A1 (es) | 2001-09-12 | 2002-09-12 | Uso de la hl en hiperestimulacion ovarica controlada |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US7341989B2 (es) |
| EP (1) | EP1434600B1 (es) |
| JP (1) | JP2005504072A (es) |
| KR (1) | KR20040032953A (es) |
| CN (1) | CN1302806C (es) |
| AR (1) | AR036591A1 (es) |
| AT (1) | ATE427755T1 (es) |
| AU (1) | AU2002331939B2 (es) |
| BR (1) | BR0212502A (es) |
| CA (1) | CA2457067A1 (es) |
| CY (1) | CY1110487T1 (es) |
| DE (1) | DE60231892D1 (es) |
| DK (1) | DK1434600T3 (es) |
| EA (1) | EA009210B1 (es) |
| ES (1) | ES2322136T3 (es) |
| HK (1) | HK1067866A1 (es) |
| HR (1) | HRP20040070A2 (es) |
| IL (1) | IL160781A0 (es) |
| ME (1) | MEP38808A (es) |
| MX (1) | MXPA04002125A (es) |
| NO (1) | NO327154B1 (es) |
| PL (1) | PL205472B1 (es) |
| PT (1) | PT1434600E (es) |
| RS (1) | RS51505B (es) |
| SI (1) | SI1434600T1 (es) |
| UA (1) | UA78970C2 (es) |
| WO (1) | WO2003022301A2 (es) |
| ZA (1) | ZA200401008B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20050058285A (ko) * | 2002-06-07 | 2005-06-16 | 아레스 트레이딩 에스.에이. | 조절된 난소 과자극 방법 및 이런 방법에 이용되는제약학적 키트 |
| US20040248784A1 (en) * | 2003-06-03 | 2004-12-09 | Marco Filicori | Unitary combinations of FSH and hCG |
| CN102296047B (zh) * | 2011-08-13 | 2013-03-13 | 新疆农垦科学院 | 利用羔羊超排卵母细胞生产体外胚胎的方法 |
| US20150272622A1 (en) | 2011-12-22 | 2015-10-01 | Previvo Genetics, Llc | Recovery and processing of human embryos formed in vivo |
| US9282995B2 (en) * | 2011-12-22 | 2016-03-15 | Previvo Genetics, Llc | Recovery and processing of human embryos formed in vivo |
| US9216037B2 (en) | 2013-06-21 | 2015-12-22 | Previvo Genetics, Llc | Uterine lavage for embryo retrieval |
| US20160024181A1 (en) | 2013-03-13 | 2016-01-28 | Moderna Therapeutics, Inc. | Long-lived polynucleotide molecules |
| RU2629871C1 (ru) * | 2016-03-22 | 2017-09-04 | Сергей Михайлович Юдин | Препарат для стимуляции фолликулогенеза и способ его применения |
| IT202000022015A1 (it) * | 2020-09-18 | 2022-03-18 | Marca Antonio La | Nuovo uso dell'ormone luteinizzante |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4589402A (en) | 1984-07-26 | 1986-05-20 | Serono Laboratories, Inc. | Method of in vitro fertilization |
| IT1250075B (it) * | 1991-12-18 | 1995-03-30 | Serono Cesare Ist Ricerca | Composizioni farmaceutiche contenenti gonadotropine. |
| WO2000067778A1 (en) * | 1999-05-07 | 2000-11-16 | Applied Research Systems Ars Holding N.V. | Gonadotrophins |
-
2002
- 2002-09-12 KR KR10-2004-7002589A patent/KR20040032953A/ko not_active Application Discontinuation
- 2002-09-12 ME MEP-388/08A patent/MEP38808A/xx unknown
- 2002-09-12 PT PT02767637T patent/PT1434600E/pt unknown
- 2002-09-12 ES ES02767637T patent/ES2322136T3/es not_active Expired - Lifetime
- 2002-09-12 AR ARP020103455A patent/AR036591A1/es not_active Application Discontinuation
- 2002-09-12 PL PL367343A patent/PL205472B1/pl unknown
- 2002-09-12 US US10/487,423 patent/US7341989B2/en not_active Expired - Fee Related
- 2002-09-12 DE DE60231892T patent/DE60231892D1/de not_active Expired - Lifetime
- 2002-09-12 CN CNB028175743A patent/CN1302806C/zh not_active Expired - Fee Related
- 2002-09-12 MX MXPA04002125A patent/MXPA04002125A/es active IP Right Grant
- 2002-09-12 WO PCT/GB2002/004147 patent/WO2003022301A2/en active Application Filing
- 2002-09-12 EP EP02767637A patent/EP1434600B1/en not_active Revoked
- 2002-09-12 AT AT02767637T patent/ATE427755T1/de active
- 2002-09-12 EA EA200400428A patent/EA009210B1/ru not_active IP Right Cessation
- 2002-09-12 AU AU2002331939A patent/AU2002331939B2/en not_active Ceased
- 2002-09-12 RS YUP-212/04A patent/RS51505B/sr unknown
- 2002-09-12 JP JP2003526429A patent/JP2005504072A/ja active Pending
- 2002-09-12 SI SI200230815T patent/SI1434600T1/sl unknown
- 2002-09-12 BR BR0212502-1A patent/BR0212502A/pt not_active Application Discontinuation
- 2002-09-12 IL IL16078102A patent/IL160781A0/xx unknown
- 2002-09-12 DK DK02767637T patent/DK1434600T3/da active
- 2002-09-12 CA CA002457067A patent/CA2457067A1/en not_active Withdrawn
- 2002-12-09 UA UA2004031858A patent/UA78970C2/uk unknown
-
2004
- 2004-01-23 HR HR20040070A patent/HRP20040070A2/hr not_active Application Discontinuation
- 2004-02-06 ZA ZA2004/01008A patent/ZA200401008B/en unknown
- 2004-03-08 NO NO20040990A patent/NO327154B1/no not_active IP Right Cessation
-
2005
- 2005-02-22 HK HK05101453A patent/HK1067866A1/xx not_active IP Right Cessation
-
2009
- 2009-06-30 CY CY20091100694T patent/CY1110487T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0104718A2 (hu) | Mikronizált eplerenon kompozíciók és eljárás az előállításukra | |
| CY1110287T1 (el) | Χρηση της ανθρωπινης παραθυρεοειδους ορμονης | |
| ES2190244T3 (es) | Uso de la hormona paratiroidea constituida por una secuencia de aminoacidos 1-34 de la hormona paratiroidea humana para reducir el riesco de fracturas oseas vertebrales y no vertebrales. | |
| WO1997049373A3 (en) | Treatment and prevention of hiv infection by administration of derivatives of human chorionic gonadotropin | |
| HUP0100928A2 (hu) | Humán inzulin B láncának részletét tartalmazó peptidanalógok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
| ATE75945T1 (de) | Pharmazeutische zubereitung zur behandlung des diabetes mellitus. | |
| IL154888A (en) | Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid | |
| DE60236541D1 (de) | Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1 | |
| MXPA04004842A (es) | Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1. | |
| TW200631592A (en) | Soluble, stable insulin-containing formulations | |
| BR9906796A (pt) | Método para a administração de análogos de insulina monoméricos | |
| DK1146896T3 (da) | Formuleringer, som indeholder monodisperse hexamere acylerede insulin-analoger | |
| SE8802569D0 (sv) | Improvements in or relation to somatostatins | |
| TW362973B (en) | Use of 2-anino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazole as a composition having an antidepressant activity | |
| DE50012571D1 (de) | Biotin enthaltende galenische formulierung | |
| AR036591A1 (es) | Uso de la hl en hiperestimulacion ovarica controlada | |
| AR039895A1 (es) | Composicion que comprende una vitamina, una sal de metal y una insulina o una hormona del crecimiento y uso de dichos componentes para prepararla | |
| ATE505199T1 (de) | Pharmazeutische, kosmetische oder therapeutische zusammensetzungen enthaltend peptide mit dem motiv arg-gly-ser | |
| EA200301041A1 (ru) | Стимуляция остеогенеза с использованием гибридных белков лиганда для rank | |
| ATE398134T1 (de) | Neue analoga von nitrobenzylthioinosin | |
| ITTO20020684A1 (it) | Nuovo uso dell'angelicina e di suoi analoghi strutturali. | |
| PE20050285A1 (es) | Composicion farmaceutica que comprende analogos ciclicos de somatostatina | |
| SE0203817D0 (sv) | New composition | |
| DE602004009166D1 (de) | Neue Analoga von Nitrobenzylthioinosin | |
| PE20011042A1 (es) | Uso de glutamina para la prevencion de diarrea de inicio tardio inducida por irinotecan |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |